Pancreatic Cancer Research

ResearcherUniversity of LouisvilleNo recent work listed

Zhongxin Lu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3365-0881; OpenAlex author ID A5010532818. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper

Papers 3

  1. MicroRNA-301a promotes pancreatic cancer invasion and metastasis through the JAK/STAT3 signaling pathway by targeting SOCS5. Last author DOI 10.1093/carcin/bgz121↗
  2. miR-331-3p functions as an oncogene by targeting ST7L in pancreatic cancer. Co-author DOI 10.1093/carcin/bgy074↗
  3. miR-301a as an NF-κB activator in pancreatic cancer cells. Co-author DOI 10.1038/emboj.2010.296↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tianzhu Zhang · 1 shared paper, 2020 · strength 0.11
  2. Hui Hu · 1 shared paper, 2020 · strength 0.11
  3. Yi-Yuan Wan · 1 shared paper, 2018 · strength 0.07
  4. Xiaoli Chen · 1 shared paper, 2018 · strength 0.07
  5. Xiaodong Huang · 1 shared paper, 2018 · strength 0.07
  6. Ting Zhan · 1 shared paper, 2018 · strength 0.07
  7. Tian Xia · 1 shared paper, 2018 · strength 0.07
  8. Yong Li · 1 shared paper, 2011 · strength 0.03
  9. Robert C.G. Martin · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.